The Effect of Irisin as a Metabolic Regulator and Its Therapeutic Potential for Obesity
Obesity is a worldwide health problem due to the imbalance of energy intake and energy expenditure. Irisin, a newly identified exercise-responsive myokine, which is produced by the proteolytic cleavage of fibronectin type III domain-containing protein 5 (FNDC5), has emerged as a promising therapeuti...
Saved in:
Main Authors: | Hui Li, Fang Wang, Mu Yang, Jiao Sun, Yi Zhao, Dongqi Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2021/6572342 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating Irisin Levels Are Not Regulated by Nutritional Status, Obesity, or Leptin Levels in Rodents
by: Mar Quiñones, et al.
Published: (2015-01-01) -
Irisin Exerts Neuroprotective Effects on Cultured Neurons by Regulating Astrocytes
by: Kexin Wang, et al.
Published: (2018-01-01) -
Regulation of adipocyte differentiation and lipid metabolism by novel synthetic chromenes exploring anti-obesity and broader therapeutic potential
by: Kewalin Inthanon, et al.
Published: (2025-02-01) -
Relationship of serum irisin levels, physical activity, and metabolic syndrome biomarkers in obese individuals with low-calorie intake and non-obese individuals with high-calorie intake
by: Jalal Hejazi, et al.
Published: (2025-01-01) -
Irisin a Novel Metabolic Biomarker: Present Knowledge and Future Directions
by: Ilse Yessabel Martinez Munoz, et al.
Published: (2018-01-01)